Effects of Tribulus Terrestris in Women With Hypoactive Sexual Desire Disorder
Launched by FEDERAL UNIVERSITY OF MINAS GERAIS · Oct 28, 2013
Trial Information
Current as of May 11, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • regular menstrual cycle
- • with no use of hormonal contraception within the last 3 months
- • without any medication, drugs or alcohol.
- • Healthy patients without systemic or psychiatric disease
- Exclusion Criteria:
- • Patients with amenorrhea and/or pregnant.
- • Patients who underwent bilateral oophorectomy.
- • Patient smoker (10 cigarettes per day).
- • Patients with blood pressure \> 160/90 mm Hg.
- • Patient with breast or endometrial carcinoma.
- • Patients with a history of myocardial infarction.
- • Patient with Diabetes.
- • Patient with vaginal bleeding from any source.
- • Patients with hepatic injury.
- • Patients with active thrombophlebitis or thromboembolic disorders recent
- • Patients with interpersonal relationship problems with your relationship or partner
- • Patients with sexual problems from your partner
About Federal University Of Minas Gerais
The Federal University of Minas Gerais (UFMG) is a prestigious academic institution in Brazil, renowned for its commitment to advancing research and education in the health sciences. With a strong emphasis on innovation and collaboration, UFMG conducts clinical trials that aim to improve patient outcomes and enhance medical knowledge. The university is equipped with cutting-edge facilities and a diverse team of experts dedicated to ethical research practices, contributing significantly to the global scientific community. Through its clinical trial initiatives, UFMG strives to address pressing health challenges and promote evidence-based solutions for better healthcare delivery.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Belo Horizonte, Minas Gerais, Brazil
Patients applied
Trial Officials
Selmo Geber, MD PhD
Principal Investigator
Federal University of Minas Gerais
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials